Profile of Stroke Patients with COVID-19 at Rumah Sakit Islam Surabaya Jemursari, Indonesia
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Shobihatus Syifak
Dyah Yuniati
Prima Ardiansyah Surya
Vena Saskia Prima Saffanah
Abstract
Background: Stroke is the number one cause of death in Indonesia, in America stroke is also the number one cause of disability. In COVID-19, most patients experience mild to moderate respiratory symptoms, and need no specific treatment. However, in some patients with comorbidities such as cardiovascular, diabetes mellitus, chronic respiratory disease, and malignancy, it often gives serious manifestation.
Objective: This study aimed to profile of stroke patients with COVID-19 at Rumah Sakit Islam Surabaya Jemursari, Indonesia.
Method: The type of this research was observational retrospective research. We used all the stroke patient hospitalized at Rumah Sakit Islam Surabaya Jemursari from April to December 2020 that confirmed the diagnosis of COVID-19. We used the general data, data of clinical symptoms, blood pressure, head CT-scan findings, and laboratory findings the data of participants was collected. The data showed as number (frequency) and percentage.
Results: The patient’s average age of 57 years, male was common; patients with hypertension were often seen in the comorbidities; ischemic strokes were by far the most prevalent form; subcortical regions were the most frequent location of stroke based on the CT scan. The results of head CT showed that 91.7% of patients had an ischemic stroke and 8.3% of patients had a hemorrhagic stroke.
Conclusions: The stroke patients with COVID-19 and hospitalized at Rumah Sakit Islam Surabaya Jemursari, Indonesia have an average age of 57 year, and most of the patient was male. Comorbid hypertension was commonly observed in this study. Based on the type of stroke, ischemic was the most common manifestation and subcortical regions were the most frequent location.
Downloads
##plugins.themes.bootstrap3.article.details##
Copyright (c) 2023 Shobihatus Syifak, Dyah Yuniati, Prima Ardiansyah Surya, Vena Saskia Prima Saffanah
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Aisyah, D. N. et al. (2022) ‘Building on health security capacities in Indonesia: Lessons learned from the COVID-19 pandemic responses and challenges’, Zoonoses and Public Health, (April), pp. 1–11. doi: 10.1111/zph.12976.
Bhatia, R. et al. (2020) ‘Stroke in coronavirus disease 2019: A systematic review’, Journal of Stroke, 22(3), pp. 324–335. doi: 10.5853/jos.2020.02264.
David Spence, J. et al. (2020) ‘Mechanisms of Stroke in COVID-19’, Cerebrovascular Diseases, 49(4), pp. 451–458. doi: 10.1159/000509581.
Gupta, A. et al. (2020) ‘Extrapulmonary manifestations of COVID-19’, Nature Medicine, 26(7), pp. 1017–1032. doi: 10.1038/s41591-020-0968-3.
Hidayat, R. et al. (2022) ‘Ischemic stroke in COVID-19 patients: a cross-sectional study from an Indonesian COVID-19 referral hospital’, Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 58(1). doi: 10.1186/s41983-022-00528-z.
Iqbal, Y. et al. (2021) ‘Ischaemic stroke as the presenting feature of covid-19: A series of three cases from Qatar’, Oxford Medical Case Reports, 2021(3), pp. 109–112. doi: 10.1093/omcr/omab006.
Katz, J. M. et al. (2021) ‘COVID-19 Severity and Stroke: Correlation of Imaging and Laboratory Markers’, American Journal of Neuroradiology, 42(2), pp. 257–261. doi: 10.3174/ajnr.A6920.
Khorvash, F. et al. (2019) ‘New‑onset acute ischemic stroke following COVID‑19: A case–control study’, Journal of Research in Medical Sciences, 24(1), pp. 1–5. doi: 10.4103/jrms.JRMS.
Kim, Y. et al. (2021) ‘Predicting In-hospital Mortality Using D-Dimer in COVID-19 Patients With Acute Ischemic Stroke’, Frontiers in Neurology, 12(July), pp. 1–6. doi: 10.3389/fneur.2021.702927.
Luo, W. et al. (2022) ‘Ischemic stroke associated with COVID-19: a systematic review and meta-analysis’, Journal of Neurology, 269(4), pp. 1731–1740. doi: 10.1007/s00415-021-10837-7.
Nannoni, S. et al. (2021) ‘Stroke in COVID-19: A systematic review and meta-analysis’, International Journal of Stroke, 16(2), pp. 137–149. doi: 10.1177/1747493020972922.
Nicholson, P., Alshafai, L. and Krings, T. (2020) ‘Neuroimaging findings in patients with COVID-19’, American Journal of Neuroradiology, 41(8), pp. 1380–1383. doi: 10.3174/AJNR.A6630.
Ortega-Paz, L. et al. (2021) ‘Coronavirus disease 2019–associated thrombosis and coagulopathy: Review of the pathophysiological characteristics and implications for antithrombotic management’, Journal of the American Heart Association, 10(3), pp. 1–24. doi: 10.1161/JAHA.120.019650.
Pane, R. V., Donastin, A. and Al Hajiri, A. Z. Z. (2022) ‘Comparison of Regular Rehabilitation Program with Additional Reciting Holy Qur’an on Cardiorespiratory Fitness among Covid-19 Survivors’, Journal Of The Indonesian Medical Association, 72(5), pp. 233–238. doi: 10.47830/jinma-vol.72.5-2022-812.
Requena, M. et al. (2020) ‘COVID-19 and Stroke: Incidence and Etiological Description in a High-Volume Center’, Journal of Stroke and Cerebrovascular Diseases, 29 No. 11(January), p. 105225.
Shakil, S. S. et al. (2022) ‘Stroke among Patients Hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry’, Stroke, 29(2), pp. 800–807. doi: 10.1161/STROKEAHA.121.035270.
Shibata, S. et al. (2020) ‘Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19’, Hypertension Research, 43(10), pp. 1028–1046. doi: 10.1038/s41440-020-0515-0.
Singh, G. et al. (2020) ‘Stroke: Causes and Clinical Features’, Medicine (Abingdon, England : UK Ed.), 48(9)(January), pp. 561–566.
Sungkar, E. (2021) ‘Disability in post Covid-19 Era’, Indonesian Journal of Physical Medicine and Rehabilitation, 2(2), pp. 5–10. doi: 10.31920/2633-2116/2021/v2n1a0.
Trifan, G. et al. (2020) ‘Characteristics of a Diverse Cohort of Stroke Patients with SARS-CoV-2 and Outcome by Sex’, Journal of Stroke and Cerebrovascular Diseases, 29(11), pp. 1–8. doi: 10.1016/j.jstrokecerebrovasdis.2020.105314.